Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

This publication has 37 references indexed in Scilit:

• Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task
  International Journal of Cardiology, 2006
• Translating the Results of Randomized Trials into Clinical Practice
  Stroke, 2006
• Applicability to primary care of national clinical guidelines on blood pressure lowering for people with stroke: cross sectional study
  BMJ, 2006
• Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary Care
  Stroke, 2005
• Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
  The American Journal of Cardiology, 2005
• Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation
  Age and Ageing, 2004
• Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
  The Lancet, 2003
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
  The Lancet, 1993
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
  Stroke, 1991